Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg. Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019
Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012
Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers) Source: International Congress 2017 – Smoking and health hazards Year: 2017
Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015
Radiological findings and isolation days of pulmonary tuberculosis patients – comparison between active smokers and non-smokers/former-smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
Smoking status and long term clinical outcome in patients with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
The features of sarcoidosis in owerweight patients. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Eosinophilic lung disease: clinical features of 25 patients Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006
Bronchial carcinoid tumors of thorax: demographic, clinical and radiological findings in 21 patients Source: Eur Respir J 2005; 26: Suppl. 49, 213s Year: 2005
Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012
Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome Source: Annual Congress 2013 –Asthma at the bedside Year: 2013
Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Do typical and atypical HRCT patterns make difference in prognosis of patients with IPF? Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016
Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients Source: Eur Respir J 2003; 22: Suppl. 45, 43s Year: 2003